1. Поляков Д. С., Фомин И. В., Беленков Ю. Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14. doi:10.18087/cardio.2021.4.n1628.
2. Глезер М. Г., Чернявская Т. К. Современные подходы к организации помощи пациентам с сердечной недостаточностью. Кардиология. 2020;60(8):106-14. doi:10.18087/cardio.2020.8.n866.
3. Padwal R, Wood PW. Digital Health Approaches for the Assessment and Optimisation of Hypertension Care Provision. Can J Cardiol. 2021;37(5):711-21. doi:10.1016/j.cjca.2020.12.009.
4. Planinc I, Milicic D, Cikes M. Telemonitoring in Heart Failure Management. Card Fail Rev. 2020;6:e06. doi:10.15420/cfr.2019.12.
5. Гаранин А. А., Рубаненко А. О., Шипунов И. Д., Рогова В. С. Методики измерения частоты дыхания, основанные на анализе движений грудной клетки. Наука и инновации в медицине. 2023;8(4):251-8. doi:10.35693/2500-1388-2023-8-4-251-258.
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700.
7. Napier R, McNulty SE, Eton DT, et al. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2018;6(7):552-60. doi:10.1016/j.jchf.2018.02.006.
8. Tsiachristas A, Potter CM, Rocks S, et al. Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8). Health Qual Life Outcomes. 2020;18(1):279. doi:10.1186/s12955-020-01506-w.
9. Balestroni G, Bertolotti G. L'EuroQol-5D (EQ-5D): uno strumento per la misura della qualità della vita [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis. 2012;78(3):155-9. doi:10.4081/monaldi.2012.121.
10. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.
11. Emel'yanov AV, Zheleznykh EA, Kozhevnikova MV, et al. Influence of remote digital observations on quality of life, compliance, and clinical outcomes in patients with chronic heart failure. Biomed Eng. 2024;57:311-5. doi:10.1007/s10527-023-10322-7.
12. Hwang R, Bruning J, Morris NR, et al. Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure: a randomised trial. J Physiother. 2017;63(2):101-7. doi:10.1016/j.jphys.2017.02.017.
13. Pekmezaris R, Nouryan CN, Schwartz R, et al. A Randomized Controlled Trial Comparing Telehealth Self-Management to Standard Outpatient Management in Underserved Black and Hispanic Patients Living with Heart Failure. Telemed J E Health. 2019;25(10):917-25. doi:10.1089/tmj.2018.0219.
14. Delaney C, Apostolidis B, Bartos S, et al. A Randomized Trial of Telemonitoring and Self-Care Education in Heart Failure Patients Following Home Care Discharge. Home Health Care Management & Practice. 2013;25(5):187-95. doi:10.1177/1084822312475137.
15. Hudiyawati D, Nur Rosyid F, Pratiwi A, et al. The Effect of Structured Education and Telemonitoring on Self-care, Self-efficacy and Quality of Life in Heart Failure Patients: A Randomized Controlled Trial. Evidence Based Care. 2023;13(3):7-16. doi:10.22038/ebcj.2023.69805.2819.
16. López-Liria R, López-Villegas A, Enebakk T, et al. Telemonitoring and Quality of Life in Patients after 12 Months Following a Pacemaker Implant: the Nordland Study, a Randomised Trial. Int J Environ Res Public Health. 2019;16(11):2001. doi:10.3390/ijerph16112001.
17. Hale TM, Jethwani K, Kandola MS, et al. A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study. J Med Internet Res. 2016;18(5):e91. doi:10.2196/jmir.5256. Erratum in: J Med Internet Res. 2019;21(2):e13125. doi:10.2196/13125.
18. Ding H, Jayasena R, Chen SH, et al. The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial. J Med Internet Res. 2020;22(7):e17559. doi:10.2196/17559.
19. Nouryan CN, Morahan S, Pecinka K, et al. Home Telemonitoring of Community-Dwelling Heart Failure Patients After Home Care Discharge. Telemed J E Health. 2019;25(6): 447-54. doi:10.1089/tmj.2018.0099.
20. Gingele AJ, Ramaekers B, Brunner-La Rocca HP, et al. Effects of tailored telemonitoring on functional status and health-related quality of life in patients with heart failure. Neth Heart J. 2019;27:565-74. doi:10.1007/s12471-019-01323-x.
21. Rebolledo Del Toro M, Herrera Leaño NM, Barahona-Correa JE, et al. Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of literature and meta-analysis. Heart Fail Rev. 2023;28(2):431-52. doi:10.1007/s10741-022-10291-1.
22. Faragli A, Abawi D, Quinn C, et al. The role of non-invasive devices for the telemonitoring of heart failure patients. Heart Fail Rev. 2021;26(5):1063-80. doi:10.1007/s10741-020-09963-7.
23. Kitsiou S, Paré G, Jaana M. Effects of home telemonitoring interventions on patients with chronic heart failure: an overview of systematic reviews. J Med Internet Res. 2015;17(3):e63. doi:10.2196/jmir.4174.
24. Vittorii S, Zuin M, Paolini C, et al. Il telemonitoraggio territoriale dei pazienti affetti da scompenso cardiaco cronico. I risultati di uno studio pilota nel Veneto [Telemonitoring patients with chronic heart failure. Results from a pilot study in the Veneto Region, Italy]. G Ital Cardiol (Rome). 2023;24(9):741-50. doi:10.1714/4084.40684.
25. Drews TEI, Laukkanen J, Nieminen T. Non-invasive home telemonitoring in patients with decompensated heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8(5):3696-708. doi:10.1002/ehf2.13475.